Literature DB >> 16890654

Percutaneous computerized tomography guided renal cryoablation using local anesthesia: pain assessment.

Sompol Permpongkosol1, Aaron Sulman, Stephen B Solomon, Gary X Gong, Louis R Kavoussi.   

Abstract

PURPOSE: The administration of intravenous sedation during prone computerized tomography guided, percutaneous procedures has the potential for complications. We assessed the pain associated with computerized tomography guided, percutaneous renal cryoablation using straight local anesthesia.
MATERIALS AND METHODS: Patients were treated with cryoablation probes inserted into the renal tumor under computerized tomography guidance with local anesthesia. Patients were asked to rate the pain experienced during needle placement and cryoablation using a visual 10-degree pain score scale. Sedation was given when pain was greater than 7 or when requested by the patient. Parameters assessed were cardiopulmonary complications, the need for intravenous supplementation, the pain score during the procedure and the postoperative score.
RESULTS: A total of 25 patients (30 tumors) underwent a total of 26 cryoablation sessions with only local anesthesia. Mean patient age +/- SD was 67 +/- 13 years (range 33 to 88). Average tumor and ice ball size was 2.1 +/- 0.7 (range 1.1 to 4.3) and 4.1 +/- 1.0 cm (range 2.6 to 5.9), respectively. The mean dose of 1% lidocaine was 43.89 +/- 24.97 ml (range 10 to 110). All procedures were completed in an average of 68.78 +/- 20.7 minutes (range 40 to 120). Vital signs were not significantly changed during the procedure. Successful completion of percutaneous computerized tomography guided cryoablation using local anesthesia was accomplished in 22 of the 26 sessions (84.62%) without sedation. Four patients required intravenous supplementation.
CONCLUSIONS: Percutaneous computerized tomography guided cryoablation for renal tumors can be performed using local anesthesia with minimal discomfort in most patients.

Entities:  

Mesh:

Year:  2006        PMID: 16890654     DOI: 10.1016/j.juro.2006.04.035

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Percutaneous cryoablation in early stage hepatocellular carcinoma: analysis of local tumor progression factors.

Authors:  Dong Kyu Kim; Kichang Han; Jong Yun Won; Gyoung Min Kim; Joon Ho Kwon; Man Deuk Kim
Journal:  Diagn Interv Radiol       Date:  2020-03       Impact factor: 2.630

Review 2.  Current State of Tumor Ablation Therapies.

Authors:  Christopher W Bailey; Malcolm K Sydnor
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

3.  Safety and effectiveness of percutaneous renal cryoablation with conscious sedation.

Authors:  Sagar Rohitkumar Patel; Sean Francois; Tiagpaul Bhamber; Holt Evans; Kris Gaston; Stephen B Riggs; Chris Teigland; Peter E Clark; Ornob P Roy
Journal:  Arab J Urol       Date:  2020-03-23

4.  Percutaneous cryoablation for hepatocellular carcinoma.

Authors:  Kyoung Doo Song
Journal:  Clin Mol Hepatol       Date:  2016-12

Review 5.  Recent Perspectives on the Mechanism of Recurrence After Ablation of Hepatocellular Carcinoma: A Mini-Review.

Authors:  Jianquan Yang; Wen Guo; Man Lu
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.